Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI)
Bone Marrow Transplantation2016Vol. 51(11), pp. 1499–1503
Citations Over Time
Pauline Rettman, Florent Malard, Nolwenn Legrand, Odile Avinens, J-F Eliaou, Christophe Picard, Anne Dormoy, Xavier Lafarge, M. De Matteis, Anne Kennel, Philippe M. Loiseau, Anne Devys, Ali Boudifa, Léna Absi, M Fort, D Masson, Fabienne Quainon, I Théodorou, A Batho, A. Parissiadis, Florent Delbos, M. Drouet, David Senitzer, Évelyne Marry, Nicole Raus, Ibrahim Yakoub‐Agha, A. Cesbron, Christelle Retière, Katia Gagne
Related Papers
- → Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells(2019)26 cited
- → Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation(2014)16 cited
- Umbilical cord blood transplantation for treatment of non-malignant disorders(2010)
- [New techniques for umbilical cord blood transplantation].(2013)
- Dynamic observation on engraftment status of transplantation with two units of HLA-B mismatched umbilical cord blood.(2003)